Clients Hail Standard Chartered's Market Outlook for 2025 as Best-in-Class Wealth and Investment ...
Standard Chartered Bank's recent Market Outlook event has received resounding praise from clients, with many hailing it as the ...
Dignify Therapeutics, a biotechnology company dedicated to restoring voluntary bowel and bladder function in patients with ...
Highlights,Mineralys Therapeutics' stock opened at $10.15, reflecting recent market adjustments.,Executive transactions ...
Highlights,Financial institutions have adjusted their outlook on Axsome Therapeutics, revising expectations.,Institutional ...
Patients Achieved Remission Within 30 Days in Cohort 1 of the Mipletamig RAINIER Dose Optimization Trial for Frontline AML Patients, Trial Enrollment Continues Promising Data, including a 59% Stable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback